Author
Listed:
- C. L. Wilson
(Fibrosis Research Group, Institute of Cellular Medicine, Newcastle University)
- D. Jurk
(Newcastle University Institute for Ageing and Institute for Cell and Molecular Biosciences, Newcastle University)
- N. Fullard
(Fibrosis Research Group, Institute of Cellular Medicine, Newcastle University)
- P. Banks
(Fibrosis Research Group, Institute of Cellular Medicine, Newcastle University)
- A. Page
(Fibrosis Research Group, Institute of Cellular Medicine, Newcastle University)
- S. Luli
(Fibrosis Research Group, Institute of Cellular Medicine, Newcastle University)
- A. M. Elsharkawy
(Liver Unit, University Hospitals Birmingham)
- R. G. Gieling
(Hypoxia and Therapeutics Group, Manchester Pharmacy School, University of Manchester)
- J. Bagchi Chakraborty
(Immunology and Inflammation, Imperial College of Science, Technology and Medicine, Hammersmith Hospital)
- C. Fox
(Fibrosis Research Group, Institute of Cellular Medicine, Newcastle University)
- C. Richardson
(Centre for Behaviour and Evolution/Institute of Neuroscience, Medical School, Newcastle University)
- K. Callaghan
(Fibrosis Research Group, Institute of Cellular Medicine, Newcastle University)
- G. E. Blair
(Faculty of Biological Sciences, School of Molecular and Cellular Biology, University of Leeds)
- N. Fox
(Faculty of Biological Sciences, School of Molecular and Cellular Biology, University of Leeds)
- A. Lagnado
(Newcastle University Institute for Ageing and Institute for Cell and Molecular Biosciences, Newcastle University)
- J. F. Passos
(Newcastle University Institute for Ageing and Institute for Cell and Molecular Biosciences, Newcastle University)
- A. J. Moore
(Institute for Cell and Molecular Biosciences, Newcastle University)
- G. R. Smith
(Fibrosis Research Group, Institute of Cellular Medicine, Newcastle University)
- D. G. Tiniakos
(Fibrosis Research Group, Institute of Cellular Medicine, Newcastle University)
- J. Mann
(Fibrosis Research Group, Institute of Cellular Medicine, Newcastle University)
- F. Oakley
(Fibrosis Research Group, Institute of Cellular Medicine, Newcastle University)
- D. A. Mann
(Fibrosis Research Group, Institute of Cellular Medicine, Newcastle University)
Abstract
Hepatocellular carcinoma (HCC) develops on the background of chronic hepatitis. Leukocytes found within the HCC microenvironment are implicated as regulators of tumour growth. We show that diethylnitrosamine (DEN)-induced murine HCC is attenuated by antibody-mediated depletion of hepatic neutrophils, the latter stimulating hepatocellular ROS and telomere DNA damage. We additionally report a previously unappreciated tumour suppressor function for hepatocellular nfkb1 operating via p50:p50 dimers and the co-repressor HDAC1. These anti-inflammatory proteins combine to transcriptionally repress hepatic expression of a S100A8/9, CXCL1 and CXCL2 neutrophil chemokine network. Loss of nfkb1 promotes ageing-associated chronic liver disease (CLD), characterized by steatosis, neutrophillia, fibrosis, hepatocyte telomere damage and HCC. Nfkb1S340A/S340Amice carrying a mutation designed to selectively disrupt p50:p50:HDAC1 complexes are more susceptible to HCC; by contrast, mice lacking S100A9 express reduced neutrophil chemokines and are protected from HCC. Inhibiting neutrophil accumulation in CLD or targeting their tumour-promoting activities may offer therapeutic opportunities in HCC.
Suggested Citation
C. L. Wilson & D. Jurk & N. Fullard & P. Banks & A. Page & S. Luli & A. M. Elsharkawy & R. G. Gieling & J. Bagchi Chakraborty & C. Fox & C. Richardson & K. Callaghan & G. E. Blair & N. Fox & A. Lagnad, 2015.
"NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinoma,"
Nature Communications, Nature, vol. 6(1), pages 1-15, November.
Handle:
RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms7818
DOI: 10.1038/ncomms7818
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms7818. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.